BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

North America

Johnson & Johnson’s Amivantamab–Lazertinib Combo Extends Survival Beyond Four Years in Asia NSCLC Cohort

Median overall survival in Asia cohort is projected to exceed four years, demonstrating a durable benefit and surpassing osimertinib monotherapy by more th...

September 17, 2025 | News

Eli Lilly to Invest $5 Billion in New Virginia API and Bioconjugate Manufacturing Facility

New site in Virginia's Goochland County will develop active pharmaceutical ingredients (API) in the U.S. for cancer, autoimmune and other ad...

September 17, 2025 | News

US, China and Australia Begin Phase 2 Trial of Atom Therapeutics’ ABP-745 for Acute Gout Flares

ABP-745 is an oral small molecule drug with potential applications, for other inflammatory conditions such as cardiovascular disease Atom T...

September 17, 2025 | News

Biostar Pharma Doses First Patients in Two Global Phase II/III Trials of Oral Utidelone Capsule for Gastric and Ovarian Cancers

Biostar Pharma, Inc., the US subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. ("Biostar", Stock Code: 2563.HK) which is a synthetic biolo...

September 16, 2025 | News

Rona Therapeutics Submits RN3161 to Australian HREC as INHBE-Targeting GalNAc siRNA for Obesity

Rona Therapeutics, a global leader in developing next-generation RNAi therapeutics, announced the successful submission of RN3161 to the Australian Human R...

September 16, 2025 | News

LabConnect and OmniScience Partner to Launch Industry’s First AI Control Tower for Clinical Trial Lab Data

Together we're unlocking the true potential of clinical trial lab data, bringing faster insights, smarter decisions, and better outcomes. -- LabConn...

September 16, 2025 | News

Thermo Fisher Scientific Introduces Gibco™ Efficient-Pro™ Medium (+) Insulin to Boost Titers by Up to 61% and Streamline Bioproduction

Next-generation medium delivers up to 61% higher titers1, faster workflows, and greater flexibility for insulin-dependent CHO cell lines Thermo Fisher Sci...

September 16, 2025 | News

DHL Supply Chain Expands Healthcare Footprint with Acquisition of SDS Rx

Acquisition will add long-term care and specialty pharmacies, radiopharmacies, and health system networks to DHL Supply Chain’s life sciences and h...

September 15, 2025 | News

Pulnovo Medical Secures Dual FDA IDE Approvals and CMS Coverage for PADN Clinical Trials in the U.S.

Pulnovo Medical, a globally recognized leader in medical devices for pulmonary hypertension (PH) and heart failure (HF), is proud to announce that its PADN...

September 15, 2025 | News

B. Braun Acquires True Digital Surgery to Accelerate Innovation in 3D Robotic Microsurgery

Acquisition to Enhance Technological Advancements and Expand Market Share in Digital Microsurgery B. Braun SE, a leading medical technology company,...

September 15, 2025 | News

Cytiva and WhiteLab Genomics Partner to Accelerate AAV Genomic Medicine Development

Collaboration will help reduce stable cell line development timelines in AAV genomic medicine development and ultimately also shorten development timelin...

September 11, 2025 | News

Innorna completes Phase II enrollment for IN006, the first bivalent RSV mRNA vaccine

Innorna announced the completion of enrollment and vaccination in its Phase II clinical trial for IN006, the world’s first bivalent respiratory...

September 11, 2025 | News

AGC Biologics Seattle Site Achieves New Heights in Manufacturing Excellence

Manufacturing excellence positions Seattle site as premier destination for mammalian and microbial biologic production in thriving Pacific Northwest life...

September 11, 2025 | News

MasterControl Surpasses $200 Million in Annual Recurring Revenue

MasterControl, a leading provider of quality, manufacturing, and asset management software for regulated industries, today announced it has surpassed $200 ...

September 09, 2025 | News

Stay Connected